ETFs For Biotech’s Positive Results
Amid the roller coaster of optimism and pessimism regarding trade talks with China in recent weeks, one thing that has remained consistent is positive earnings… Read More »ETFs For Biotech’s Positive Results
Biotech Stocks
ETFs To Play Biotech’s Favorable Prognosis
Mergers and acquisitions. Positive pipeline-related advancements. The integration of artificial intelligence. These are some of the key trends currently favoring the biotechnology sector – and… Read More »ETFs To Play Biotech’s Favorable Prognosis
A Healthy Trade (In More Ways Than One)
With the IBB biotechnology ETF poised to have its best quarter in six years and analysts seeing further upside for the space, biotech appears to… Read More »A Healthy Trade (In More Ways Than One)
Biotech’s 2019 “Plot Twist”
After a rough end to 2018, with massive fund outflows in the fourth quarter, biotech’s condition has been improving in 2019 – and these two… Read More »Biotech’s 2019 “Plot Twist”
Biotech Is On The Mend
After finding itself among the most oversold sectors last year, biotech is having its best start to a year since 2012 – a rally fueled… Read More »Biotech Is On The Mend
The New – And More Effective – Female Viagra: An Attractive Opportunity?
This biotech company’s drug for treating hypoactive sexual desire disorder in women is expected to receive FDA approval in early January 2019. With increasing market… Read More »The New – And More Effective – Female Viagra: An Attractive Opportunity?
The New Paradigm For Biotech Investing
There are very few diseases for which actual cures have been developed – but that could soon start to change. And with a “golden age… Read More »The New Paradigm For Biotech Investing
Bargain Bin & Analyst Adored
These three stocks – including a clinical-stage biotech with a still-promising drug candidate – may be under-performing at the moment, but some of Wall Street’s… Read More »Bargain Bin & Analyst Adored
- « Previous
- 1
- 2
- 3